Welcome to Medications.com

Ranbaxy’s Q3 PAT increases 48%, stands at Rs 2074mn - Moneycontrol.com (press release)

... Isoptin SR (Verapamil SR), following an acquisition of the product registration from FSC Laboratories, Inc. of Charlotte, North Carolina, USA. ...

http://www.moneycontrol.com/india... | Posted: Thu Oct 18 03:55:23 -0400 2007




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea